BioOutsource To Open New Biosimilar Center of Excellence - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

BioOutsource To Open New Biosimilar Center of Excellence



BioOutsource, a leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, will open a new Biosimilar Center of Excellence in Glasgow. The new facility will double the company’s capacity for the analysis of biosimilar monoclonal antibodies.

The Biosimilar Center of Excellence is located on the West of Scotland Science Park in Glasgow, adjacent to the existing BioOutsource facility. The new operation will consist of approximately 40 laboratory and R&D scientists creating an estimated 20 new jobs.

Source: BioOutsource

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here